Breast cancer diagnosis

The role of stereotactic vacuum-assisted aspiration biopsy

Francesca Rovera, Gianlorenzo Dionigi, Marina Marelli, Alberta Ferrari, Giorgio Limonta, Adriana Dionigi Corben, Luigi Boni, Cristiano Piscopo, Valentina De Berardinis, Renzo Dionigi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: The aim of this study is to evaluate the diagnostic accuracy and impact of the stereotactic vacuum-assisted aspiration biopsy (VAB) as a surgical treatment for non-palpable breast lesions. Methods: A retrospective analysis of the diagnostic and therapeutic management of lesions having undergone VAB treatment was conducted. From February 2003 to September 2007, 525 stereotactic VABs were performed on 504 women using an 11-gauge needle device. Of these, 201 lesions were treated surgically. The concordance between VAB results and final pathology report after surgical excision was evaluated. Also examined was the impact of VAB on the quality of the surgical treatment. Results: Stereotactic VABs performed with an 11-gauge device showed an underestimation rate of 23.8% for atypical ductal or lobular hyperplasia (AH). For ductal carcinoma in situ (DCIS) the underestimation rate was 31% and the underestimation rate for lobular carcinoma in situ (LCIS) was 14%. Only 38.2% of the patients with non-palpable lesions (201/525) were treated surgically and only 4% (20/504) of the patients underwent more than one surgical intervention. The VAB underestimation caused mistakes in the planning of the surgical therapy in only 9 out of 201 interventions (4.4%). Conclusions: This study confirms the efficacy of the VAB procedure in the diagnosis of non-palpable breast lesions and demonstrates its usefulness in therapeutic surgical planning. VAB treatment allows for the reduction of the number of surgical procedures required to diagnose and treat non-palpable breast lesions.

Original languageEnglish
JournalInternational Journal of Surgery
Volume6
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2008

Fingerprint

Needle Biopsy
Vacuum
Breast Neoplasms
Breast
Therapeutics
Equipment and Supplies
Carcinoma, Intraductal, Noninfiltrating
Needles
Hyperplasia
Pathology

Keywords

  • Breast cancer
  • Mammotome
  • Stereotactic vacuum-assisted aspiration biopsy

ASJC Scopus subject areas

  • Surgery

Cite this

Breast cancer diagnosis : The role of stereotactic vacuum-assisted aspiration biopsy. / Rovera, Francesca; Dionigi, Gianlorenzo; Marelli, Marina; Ferrari, Alberta; Limonta, Giorgio; Corben, Adriana Dionigi; Boni, Luigi; Piscopo, Cristiano; De Berardinis, Valentina; Dionigi, Renzo.

In: International Journal of Surgery, Vol. 6, No. SUPPL. 1, 2008.

Research output: Contribution to journalArticle

Rovera, F, Dionigi, G, Marelli, M, Ferrari, A, Limonta, G, Corben, AD, Boni, L, Piscopo, C, De Berardinis, V & Dionigi, R 2008, 'Breast cancer diagnosis: The role of stereotactic vacuum-assisted aspiration biopsy', International Journal of Surgery, vol. 6, no. SUPPL. 1. https://doi.org/10.1016/j.ijsu.2008.12.009
Rovera, Francesca ; Dionigi, Gianlorenzo ; Marelli, Marina ; Ferrari, Alberta ; Limonta, Giorgio ; Corben, Adriana Dionigi ; Boni, Luigi ; Piscopo, Cristiano ; De Berardinis, Valentina ; Dionigi, Renzo. / Breast cancer diagnosis : The role of stereotactic vacuum-assisted aspiration biopsy. In: International Journal of Surgery. 2008 ; Vol. 6, No. SUPPL. 1.
@article{f570ac1fc7e34284ba9a95d3580ba135,
title = "Breast cancer diagnosis: The role of stereotactic vacuum-assisted aspiration biopsy",
abstract = "Aim: The aim of this study is to evaluate the diagnostic accuracy and impact of the stereotactic vacuum-assisted aspiration biopsy (VAB) as a surgical treatment for non-palpable breast lesions. Methods: A retrospective analysis of the diagnostic and therapeutic management of lesions having undergone VAB treatment was conducted. From February 2003 to September 2007, 525 stereotactic VABs were performed on 504 women using an 11-gauge needle device. Of these, 201 lesions were treated surgically. The concordance between VAB results and final pathology report after surgical excision was evaluated. Also examined was the impact of VAB on the quality of the surgical treatment. Results: Stereotactic VABs performed with an 11-gauge device showed an underestimation rate of 23.8{\%} for atypical ductal or lobular hyperplasia (AH). For ductal carcinoma in situ (DCIS) the underestimation rate was 31{\%} and the underestimation rate for lobular carcinoma in situ (LCIS) was 14{\%}. Only 38.2{\%} of the patients with non-palpable lesions (201/525) were treated surgically and only 4{\%} (20/504) of the patients underwent more than one surgical intervention. The VAB underestimation caused mistakes in the planning of the surgical therapy in only 9 out of 201 interventions (4.4{\%}). Conclusions: This study confirms the efficacy of the VAB procedure in the diagnosis of non-palpable breast lesions and demonstrates its usefulness in therapeutic surgical planning. VAB treatment allows for the reduction of the number of surgical procedures required to diagnose and treat non-palpable breast lesions.",
keywords = "Breast cancer, Mammotome, Stereotactic vacuum-assisted aspiration biopsy",
author = "Francesca Rovera and Gianlorenzo Dionigi and Marina Marelli and Alberta Ferrari and Giorgio Limonta and Corben, {Adriana Dionigi} and Luigi Boni and Cristiano Piscopo and {De Berardinis}, Valentina and Renzo Dionigi",
year = "2008",
doi = "10.1016/j.ijsu.2008.12.009",
language = "English",
volume = "6",
journal = "International Journal of Surgery",
issn = "1743-9191",
publisher = "Elsevier BV",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Breast cancer diagnosis

T2 - The role of stereotactic vacuum-assisted aspiration biopsy

AU - Rovera, Francesca

AU - Dionigi, Gianlorenzo

AU - Marelli, Marina

AU - Ferrari, Alberta

AU - Limonta, Giorgio

AU - Corben, Adriana Dionigi

AU - Boni, Luigi

AU - Piscopo, Cristiano

AU - De Berardinis, Valentina

AU - Dionigi, Renzo

PY - 2008

Y1 - 2008

N2 - Aim: The aim of this study is to evaluate the diagnostic accuracy and impact of the stereotactic vacuum-assisted aspiration biopsy (VAB) as a surgical treatment for non-palpable breast lesions. Methods: A retrospective analysis of the diagnostic and therapeutic management of lesions having undergone VAB treatment was conducted. From February 2003 to September 2007, 525 stereotactic VABs were performed on 504 women using an 11-gauge needle device. Of these, 201 lesions were treated surgically. The concordance between VAB results and final pathology report after surgical excision was evaluated. Also examined was the impact of VAB on the quality of the surgical treatment. Results: Stereotactic VABs performed with an 11-gauge device showed an underestimation rate of 23.8% for atypical ductal or lobular hyperplasia (AH). For ductal carcinoma in situ (DCIS) the underestimation rate was 31% and the underestimation rate for lobular carcinoma in situ (LCIS) was 14%. Only 38.2% of the patients with non-palpable lesions (201/525) were treated surgically and only 4% (20/504) of the patients underwent more than one surgical intervention. The VAB underestimation caused mistakes in the planning of the surgical therapy in only 9 out of 201 interventions (4.4%). Conclusions: This study confirms the efficacy of the VAB procedure in the diagnosis of non-palpable breast lesions and demonstrates its usefulness in therapeutic surgical planning. VAB treatment allows for the reduction of the number of surgical procedures required to diagnose and treat non-palpable breast lesions.

AB - Aim: The aim of this study is to evaluate the diagnostic accuracy and impact of the stereotactic vacuum-assisted aspiration biopsy (VAB) as a surgical treatment for non-palpable breast lesions. Methods: A retrospective analysis of the diagnostic and therapeutic management of lesions having undergone VAB treatment was conducted. From February 2003 to September 2007, 525 stereotactic VABs were performed on 504 women using an 11-gauge needle device. Of these, 201 lesions were treated surgically. The concordance between VAB results and final pathology report after surgical excision was evaluated. Also examined was the impact of VAB on the quality of the surgical treatment. Results: Stereotactic VABs performed with an 11-gauge device showed an underestimation rate of 23.8% for atypical ductal or lobular hyperplasia (AH). For ductal carcinoma in situ (DCIS) the underestimation rate was 31% and the underestimation rate for lobular carcinoma in situ (LCIS) was 14%. Only 38.2% of the patients with non-palpable lesions (201/525) were treated surgically and only 4% (20/504) of the patients underwent more than one surgical intervention. The VAB underestimation caused mistakes in the planning of the surgical therapy in only 9 out of 201 interventions (4.4%). Conclusions: This study confirms the efficacy of the VAB procedure in the diagnosis of non-palpable breast lesions and demonstrates its usefulness in therapeutic surgical planning. VAB treatment allows for the reduction of the number of surgical procedures required to diagnose and treat non-palpable breast lesions.

KW - Breast cancer

KW - Mammotome

KW - Stereotactic vacuum-assisted aspiration biopsy

UR - http://www.scopus.com/inward/record.url?scp=63449141067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63449141067&partnerID=8YFLogxK

U2 - 10.1016/j.ijsu.2008.12.009

DO - 10.1016/j.ijsu.2008.12.009

M3 - Article

VL - 6

JO - International Journal of Surgery

JF - International Journal of Surgery

SN - 1743-9191

IS - SUPPL. 1

ER -